Cargando…
Has the time been reached for pseudopolyps to be re-enrolled in endoscopic inflammatory bowel disease scores?
Patients with inflammatory bowel diseases (IBD) represent heterogeneous groups with different characteristics and different clinical course. A great deal of effort is made to discover proxies for more severe disease needing more intense treatment and early intervention to gain the maximum therapeuti...
Autores principales: | Politis, Dimitrios S, Katsanos, Konstantinos H, Papamichael, Konstantinos, Saridi, Maria, Albani, Eleni, Christodoulou, Dimitrios K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580305/ https://www.ncbi.nlm.nih.gov/pubmed/31236195 http://dx.doi.org/10.4253/wjge.v11.i6.424 |
Ejemplares similares
-
Pseudopolyps in inflammatory bowel diseases: Have we learned enough?
por: Politis, Dimitrios S, et al.
Publicado: (2017) -
Presence of pseudopolyps in ulcerative colitis is associated with a higher risk for treatment escalation
por: Politis, Dimitrios S., et al.
Publicado: (2019) -
The efficacy of immunomodulators in the prevention and suppression of anti-drug antibodies to anti-tumor necrosis factor therapy in inflammatory bowel disease
por: Fousekis, Fotios S., et al.
Publicado: (2022) -
Inflammatory Bowel Disease and Patients With Mental Disorders: What Do We Know?
por: Fousekis, Fotios S., et al.
Publicado: (2021) -
Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy
por: Giagkou, Eftychia, et al.
Publicado: (2018)